Familial GI stromal tumor with loss of heterozygosity and amplification of mutant KIT

Journal of Clinical Oncology

Volumn 34, Issue 3, 2016, Pages e13-e16

  Forde, Patrick M ^a   Cochran, Rory L ^a   Boikos, Sosipatros A ^a   Zabransky, Daniel J ^a   Beaver, Julia A ^a   Meyer, Christian F ^a   Thornton, Katherine A ^a   Montgomery, Elizabeth A ^b   Lidor, Anne O ^b   Donehower, Ross C ^a   Park, Ben Ho ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR RECEPTOR;

CASE REPORT; ENZYMOLOGY; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL TUMOR; GENE AMPLIFICATION; GENETICS; HETEROZYGOSITY LOSS; HUMAN; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PEDIGREE;

BASE SEQUENCE; FEMALE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; GENE AMPLIFICATION; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; MUTATION; PEDIGREE; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 84955441100     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.51.6633     Document Type: Article

References (28)

1. Cassier PA, Ducimetière F, Lurkin A, et al: A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: Incidence and molecular distribution of GIST in a European region. Br J Cancer 103:165-170, 2010
2. Chan KH, Chan CW, Chow WH, et al: Gastrointestinal stromal tumors in a cohort of Chinese patients in Hong Kong. World J Gastroenterol 12:2223-2228, 2006
3. Kawanowa K, Sakuma Y, Sakurai S, et al: High incidence of microscopic gastrointestinal stromal tumors in the stomach. Hum Pathol 37:1527-1535, 2006
4. Mussi C, Schildhaus HU, Gronchi A, et al: Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1. Clin Cancer Res 14:4550-4555, 2008
5. Agarwal R, Robson M: Inherited predisposition to gastrointestinal stromal tumor. Hematol Oncol Clin North Am 23:1-13, vii, 2009
6. Carney JA, Stratakis CA: Familial paraganglioma and gastric stromal sarcoma: A new syndrome distinct from the Carney Triad. Am J Med Genet 108:132-139, 2002
7. Corless CL, Barnett CM, Heinrich MC: Gastrointestinal stromal tumours: Origin and molecular oncology. Nat Rev Cancer 11:865-878, 2011
8. Chompret A, Kannengiesser C, Barrois M, et al: PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor. Gastroenterology 126:318-321, 2004
9. Nishida T, Hirota S, Taniguchi M, et al: Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet 19:323-324, 1998
10. National Comprehensive Cancer Network: NCCN guidelines. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp
11. Nakahara M, Isozaki K, Hirota S, et al: A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors. Gastroenterology 115:1090-1095, 1998
12. Tarn C, Merkel E, Canutescu AA, et al: Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: Therapeutic implications through protein modeling. Clin Cancer Res 11:3668-3677, 2005
13. Neuhann TM, Mansmann V, Merkelbach-Bruse S, et al: A novel germline KIT mutation (p.L576P) in a family presenting with juvenile onset of multiple gastrointestinal stromal tumors, skin hyperpigmentations, and esophageal stenosis. Am J Surg Pathol 37:898-905, 2013
14. Lasota J, vel Dobosz AJ, Wasag B, et al: Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumors. Lab Invest 87:1029-1041, 2007
15. Kleinbaum EP, Lazar AJ, Tamborini E, et al: Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor. Int J Cancer 122:711-718, 2008
16. Hindson BJ, Ness KD, Masquelier DA, et al: High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem 83:8604-8610, 2011
17. Postow MA, Robson ME: Inherited gastrointestinal stromal tumor syndromes: Mutations, clinical features, and therapeutic implications. Clin Sarcoma Res 2:16, 2012
18. de Raedt T, Cools J, Debiec-Rychter M, et al: Intestinal neurofibromatosis is a subtype of familial GIST and results from a dominant activating mutation in PDGFRA. Gastroenterology 131:1907-1912, 2006
19. Pasini B, Matyakhina L, Bei T, et al: Multiple gastrointestinal stromal and other tumors caused by platelet-derived growth factor receptor alpha gene mutations: A case associated with a germline V561D defect. J Clin Endocrinol Metab 92:3728-3732, 2007
20. Hirota S, Nishida T, Isozaki K, et al: Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT gene. Gastroenterology 122:1493-1499, 2002
21. Isozaki K, Terris B, Belghiti J, et al: Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors. Am J Pathol 157:1581-1585, 2000
22. Robson ME, Glogowski E, Sommer G, et al: Pleomorphic characteristics of a germ-line KIT mutation in a large kindred with gastrointestinal stromal tumors, hyperpigmentation, and dysphagia. Clin Cancer Res 10:1250-1254, 2004
23. Beghini A, Tibiletti MG, Roversi G, et al: Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa. Cancer 92:657-662, 2001
24. Graham J, Debiec-Rychter M, Corless CL, et al: Imatinib in the management of multiple gastrointestinal stromal tumors associated with a germline KIT K642E mutation. Arch Pathol Lab Med 131:1393-1396, 2007
25. Pasini B, McWhinney SR, Bei T, et al: Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur J Hum Genet 16:79-88, 2008
26. Wagner AJ, Remillard SP, Zhang YX, et al. Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors. Mod Pathol 26:289-294, 2013
27. Demetri GD, von Mehren M, Blanke CD, et al: Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472-480, 2002
28. Lasota J, Miettinen M: A new familial GIST identified. Am J Surg Pathol 30:1342, 2006